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ABSTRACT
A 71-year-old Japanese male patient presented with a 
rare case of Glomangiopericytoma (GPC) of the left 
nasal with obstruction. Complete resection with endo-
scopic surgery was performed. Immunohistochemical 
staining for smooth muscle actin, β catenin, cyclin D1, 
vimentin, and factor 13 were helpful in establishing 
a definitive diagnosis. Extranasal treatment has been 
traditionally performed for successful management. 
However, recent advances in endoscopic treatment 
have enabled complete endoscopic resection of GPC, 
minimizing morbidity and facilitating subsequent 
surveillance for recurrence. Endoscopic management 
should be considered in suitable cases.
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Glomangiopericytoma (GPC) is an extremely rare si-
nonasal perivascular tumor characterized by low-grade 
malignant tumor with a tendency of local recurrence. 
GPC was firstly reported as hemangiopericytoma in 
1942, but the World Health Organization classified it as 
a distinct entity in 2005.1, 2 Clinically, GPC is associ-
ated with nasal obstruction and severe nasal bleeding. 
Histologically, GPC is made up of short, bland spindle 
cells forming fascicular, storiform, or whorled patterns 
with frequent perivascular hyalinization showing immu-
noreactivity for smooth muscle actin and strong nuclear 
β-catenin. The mainstay of treatment is complete surgi-
cal extirpation to avoid recurrence. We report the case 
of a 71-year-old Japanese man who presented with left 
nasal obstruction. Complete resection with endoscopic 
surgery was performed. Diagnostic and therapeutic op-
tions are discussed in the light of the current literature.
PATIENT REPORT
A 71-year-old Japanese man was referred to our otolar-
yngology department for evaluation of nasal obstruction 
for several months. Endoscopic examination revealed a 
soft, gray, elastic mass in the left nasal cavity (Fig. 1). 
Preoperative coronal computed tomography (CT) scan 
of the paranasal sinuses showed a low-density, homo-
geneous lesion occupying the left nasal cavity (Fig. 2). 
Preoperative coronal and axial magnetic resonance 
imaging (MRI) showed that the tumor had low signal 
intensity in the T1-weighted image and low to iso signal 
intensity in the T2-weighted image (Fig. 2). CT and MRI 
indicated no evidence of intracranial extension or bony 
defect of the skull base. In case of malignancy, preop-
erative pathological examination was not performed to 
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Fig. 1. Preoperative endoscopic photograph of the left nasal 
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avoid tumor dissemination. The patient was admitted to 
our department for definitive diagnosis and treatment. 
Total endoscopic resection of the tumor was performed 
under general anesthesia. The tumor was removed with 
the use of 0-degree-of-view, 4-mm-diameter rigid endo-
scopes. Histological examination during the operation 
suggested that the tumor was a vascular tumor. Since 
the tumor adhered to the posterior middle turbinate, 
the inferior turbinate was firstly partially resected to 
obtain a clearer and well-defined visualization of the 
tumor. Next, the upper portion of the middle turbinate 
was also resected to access the tumor easily. Finally, the 
tumor was removed en bloc with the middle turbinate. 
The volume of bleeding during surgery was 50 mL. 
Histologically, it consisted of a uniform proliferation of 
ovoid to spindle-shaped cells with partially surrounding 
hyalinization and slightly branching vascular structures 
(Fig. 3). The tumor cells were positive for smooth 
muscle actin, nuclear β catenin, vimentin, factor 13, and 
cyclin D1 (Fig. 3). The definitive diagnosis was GPC. 
The patient’s condition was successfully managed with 
excision of the tumor, and he remains well with no 
evidence of recurrence 13 months after treatment.
DISCUSSION
GPC is a sinonasal perivascular tumor with low 
malignant potential,1, 2 and had been designated as an 
hemangiopericytoma-like tumor or sinonasal hemangio-
pericytoma. Its similarity with a glomus tumor, the term 
of GPC was preferred by the WHO in 2005.1, 2 Most 
Fig. 2. Preoperative coronal CT scan of the paranasal sinuses showed a low-density, homogeneous lesion occupying the left nasal cavity 
(A). Preoperative coronal and axial MRI showed that the tumor had low signal intensity in the T1-weighted image and low to iso signal 
intensity in the T2-weighted image (B–D). CT, computed tomography; MRI, magnetic resonance imaging.
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GPC are diagnosed in the sixth and seventh decades of 
age.1, 2 There is no recognized familial tendency and 
sexual predilection.1, 2 High vascularization caused by 
trauma, hypertension, pregnancy, or usage of cortico-
steroids might be involved in its pathogenesis, however, 
its etiology is still not clear.1, 2
The diagnosis of GPC is facilitated by CT or 
MRI, but a definitive diagnosis is often obtained only 
after biopsy or complete resection.2–6 For differential 
diagnosis, vascular and other tumors such as solitary 
fibrous tumors, lobular capillary hemangiomas, angiofi-
bromas, and glomus tumors should be kept in mind.7–9 
Interestingly, the expressions of cyclin D1 and β catenin 
were observed in this case. Cyclin D1 is considered 
to dysregulate the cell cycle contributing neoplastic 
transformation.7–9 Overexpression of β catenin encoded 
by CTNNB1 gene might play important role in tumori-
genesis and tumor progression.7–9 Aberrant expression 
of CTNNB1 can lead to cyclin D1 overexpression.7–9 
β catenin, a cadherin-associated membrane protein, is 
involved in the regulation of cell-to-cell adhesion and 
gene transcription as a nuclear protein.7–9 Taken to-
gether, activating β catenin and overexpression of cyclin 
D1 have a central role in pathogenesis of GPC. Recent 
reports demonstrated that strong nuclear accumulation 
of β catenin was observed in GPC and not in Glomus 
tumor.7–9 Therefore, nuclear expression of β catenin can 
be useful in distinguishing GPC and glomus tumor.4, 6–9
The treatment of choice is complete surgical 
extirpation to avoid recurrence. The recurrence rate is 
reported to be 7% to 20%; recurrence is thought to re-
sult from incomplete excision.4, 6, 7 However, endoscopic 
treatment has been attempted for tumor resection.4, 5 
Intranasal endoscopic treatment has some advantages 
over extranasal treatment. Endoscopic treatment allows 
clear visualization of each wall of the nasal cavity, and 
a precise procedure can be performed with minimum 
invasion of intact tissues. Accordingly, in juvenile 
cases, endoscopic treatment enables complete removal 
of the mass with neither postoperative facial deformity 
or subsequent abnormal development of the nose and 
paranasal sinuses.5 Although intranasal endoscopic 
treatment can be effective in most cases, anatomical 
variants such as severe septal deviation, large tumors 
or highly vascularized tumors can make it difficult.4, 6–8 
In preset cases, CT and MRI indicated no evidence of 
intracranial extension or bony defect of the skull base 
and intranasal endoscopic treatment was preferred to 
extranasal treatment. Preoperative embolization before 
resection of GPC has been recommended to reduce the 
volume of bleeding during surgery.4, 6–8
In conclusion, although GPC is extremely rare, 
it should be considered in the differential diagnosis 
of masses in the nasal cavity. Immunohistochemical 
Fig. 3. Pathological examination showed (A) uniform proliferation of oval to short spindle-shaped cells with fibrous edematous tissue, 
and hyalinization (hematoxylin and eosin staining, Bar = 100 μm). (B) From the same area, cone-shaped cells positive for anti–smooth 
muscle actin antibody can be seen (Bar = 100 μm). (C) Cone-shaped cells also positive for anti-vimentin antibody can be seen (Bar = 100 
μm). (D–F) Cone-shaped cells are also positive for (D) beta-catenin, (E) factor 13a, and (F) cyclin D1 (Bar = 100 μm).
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staining for smooth muscle actin, β catenin, cyclin D1, 
vimentin, and factor 13 are helpful in establishing a 
definitive diagnosis. Endoscopic management should be 
considered in suitable cases.
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